Sinopharm
1099.HK
$3.74
Share price
0.22%
Change (1 day)
-6.32%
Change (1 year)
Categories
The Sinopharm Group is a Chinese pharmaceutical company that researches, develops, produces, sells and markets pharmaceuticals and other health products.
Market capitalization of Sinopharm (1099.HK)
Market cap: A$11.66 Billion
As of March 2025 Sinopharm has a market cap of A$11.66 Billion. This makes Sinopharm the world's 2110th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
Market cap history of Sinopharm from 2009 to 2025
End of year Market Cap
| Year | Marketcap | Change |
|---|---|---|
| 2025 | A$11.66 B | -17.38% |
| 2024 | A$14.12 B | 17.74% |
| 2023 | A$11.99 B | 2.74% |
| 2022 | A$11.67 B | 24.7% |
| 2021 | A$9.36 B | -0.21% |
| 2020 | A$9.38 B | -39.49% |
| 2019 | A$15.50 B | -12.51% |
| 2018 | A$17.72 B | 15.64% |
| 2017 | A$15.32 B | -3.1% |
| 2016 | A$15.81 B | 3.77% |
| 2015 | A$15.24 B | 27.37% |
| 2014 | A$11.96 B | 44.83% |
| 2013 | A$8.26 B | 14.22% |
| 2012 | A$7.23 B | 28.58% |
| 2011 | A$5.62 B | -27.54% |
| 2010 | A$7.76 B | -13.33% |
| 2009 | A$8.95 B |
End of Day market cap according to different sources
On Mar 25th, 2025 the market cap of Sinopharm was reported to be:
A$11.91 Billion
A$11.91 Billion